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Abstract
Background: IL-1β and IL-1RA levels are higher in the serum of cerebral malaria patients than in
patients with mild malaria. Recently, the level of IL1B expression was reported to be influenced by
a polymorphism in the promoter of IL1, IL1B -31C>T.
Methods: To examine whether polymorphisms in IL1B and IL1RA influence the susceptibility to
cerebral malaria, IL1B  -31C>T,  IL1B  3953C>T, and IL1RA  variable number of tandem repeat
(VNTR) were analysed in 312 Thai patients with malaria (109 cerebral malaria and 203 mild malaria
patients).
Results: In this population, IL1B -31C>T and IL1RA VNTRwere detected, while IL1B 3953C>T (i.e.,
IL1B 3953T) was not observed in the polymorphism screening for 32 patients. Further analyses for
IL1B -31C>T and IL1RA VNTR in 110 cerebral malaria and 206 mild malaria patients showed no
significant association of these polymorphisms with cerebral malaria.
Conclusion: The present results suggest that IL1B -31C>T and IL1RA VNTR polymorphisms do
not play a crucial role in susceptibility or resistance to cerebral malaria.
Introduction
Interleukin 1 (IL-1) is a proinflammatory cytokine that
has been suggested to play a crucial role in the pathogen-
esis of cerebral malaria [1]. Histopathology and immuno-
histologic studies detected IL-1β in the brain and liver
from a case of fatal cerebral malaria [2]. Furthermore,
expression of IL1B mRNA was detected in the spleen, cor-
tex, cerebellum, and brain stem of most pediatric patients
that died of cerebral malaria, but it was not detected in
those of uninfected individuals [3]. In addition, the con-
centration of IL-1 receptor antagonist (IL-1RA), which
competes for receptor binding with IL-1, was also found
to be increased in Gambian children with cerebral malaria
[4]. These observations raise the question of whether pol-
ymorphisms in the genes encoding IL-1β (IL1B) and IL-
1RA (IL1RA) are associated with cerebral malaria.
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IL1  family genes including IL1B  and  IL1RA  form a
cytokine gene cluster on human chromosome 2. Recently,
the IL1B 3953C>T polymorphism, which lies in exon 5 of
IL1B, was reported to be associated with cerebral malaria
in Gambia [5]. Gyan et al. [6] reported that, in Ghanaian
Children, levels of parasitemia were significantly higher in
uncomplicated malaria patients possessing the IL1B
3953T allele (i.e., 3953T/T and 3953C/T genotypes) than
those possessing only 3953C (i.e., 3953C/C genotype),
although this polymorphism and the IL1RA  variable
number of tandem repeat (VNTR) polymorphism were
not associated with cerebral malaria.
The functional significance of the IL1B  3953C>T poly-
morphism has been studied. Some results show an associ-
ation of IL1B 3953C>T with the levels of IL-1 production
[7,8], whereas others show no association [9,10].
Recently, Kimura et al. [11] employed allele-specific tran-
script quantification to examine the effects of IL1B -31C>T
and 3953C>T polymorphisms on the level of IL-1B tran-
scription. Their results revealed that expression of the -31T
allele was significantly higher than that of the -31C allele,
while IL1B 3953C>T did not affect the expression of IL1B.
The increased level of -31T expression corresponds with
the observation that the -31T allele constitutes a TATA
sequence in the IL1B promoter and induces formation of
the transcription initiation complex [12]. Therefore, IL1B
-31C>T is an important candidate polymorphism that
may influence the susceptibility or resistance to cerebral
malaria through the upregulation of IL-1β. In addition,
the IL1RA VNTR polymorphism influences the plasma IL-
1RA levels [13], and IL-1RA modulates IL-1 production
[14], although there was no significant association of IL1B
-31C>T and IL1RA VNTR with cerebral malaria in Gambia
[5]. In this study, IL1B -31C>T, IL1B 3953C>T, and IL1RA
VNTR polymorphisms were analysed in Thai malaria
patients to examine the possible association of these pol-
ymorphisms with cerebral malaria.
Materials and methods
Subjects
A total of 316 adult patients with P. falciparum malaria
(110 cerebral malaria and 206 mild malaria patients) liv-
ing in northwest Thailand were recruited in this study. All
of them underwent treatment at the Hospital for Tropical
Diseases, Faculty of Tropical Medicine, Mahidol Univer-
sity. Clinical manifestations of malaria have been
described previously [15]. All individuals were 13 years of
age or older, and the mean ages of the mild malaria and
cerebral malaria patients were 25.5 and 28.6, respectively.
This study was approved by the institute review board of
the Faculty of Tropical Medicine, Mahidol University and
the Faculty of Medicine, The University of Tokyo.
Informed written consent was obtained from all patients.
Genotyping
Genomic DNA was extracted from peripheral blood leu-
kocytes using a QIAamp Blood Kit (Qiagen, Hilden, Ger-
many). Genotyping for the three polymorphisms was
performed as previously described [11,16]. For the IL1B
promoter polymorphism, IL1B -31C>T [11], PCR was car-
ried out with primers IL1B5'F (5'-TAGTCCCCTCCCCTAA-
GAACG-3') and IL1Bint1R (5'-
CCCAGAATATTTCCCGAGTCA-3') to amplify the region
including  IL1B  -31C>T, and the PCR products were
treated with AluI (New England Biolabs, Beverly, CA,
USA), which digests the -31T allele. For the IL1B exon 5
polymorphism, IL1B 3953C>T [11], PCR was carried out
with primers IL1Bint4F (5'-GCTCAGGTGTCCTCCAA-
GAAA-3') and IL1Bint5R (5'-GGCCAGTGCAATCAAAT-
GTG-3'), and the PCR products were treated with TaqI
(New England Biolabs), which digests the 3953C allele.
For the IL-1RA  VNTR polymorphism [16], the region
including variable numbers of identical 86-bp tandem
repeats was amplified by PCR using the following prim-
ers: 5'-CTCAGCCAACACTCCTAT-3' and 5'-TCCTGGTCT-
GCAGGTAA-3'. PCR products of 240(allele 2, two
repeats), 325 (allele 3, three repeats), 410 (allele 4, four
repeats), and 500 bp (allele 5, five repeats) were distin-
guished by agarose gel electrophoresis.
Statistical analysis
Deviation from Hardy-Weinberg equilibrium was exam-
ined with Arlequin software [17] with the default setting,
where the exact P-value is calculated based on the Markov
chain method [18]. Linkage disequilibrium (LD) between
IL1B -31C>T and IL1RA VNTR was evaluated based on the
expectation maximization (EM) algorithm using the Arle-
quin software with the default setting, where a permuta-
tion procedure is performed to calculate the P-value for
the likelihood ratio test [19]. Fisher's exact test was per-
formed to compare the genotype and allele frequency dis-
tributions between cerebral and mild malaria patients.
The P-values for association of IL1B -31C>T with cerebral
malaria were calculated based on 3 × 2 and 2 × 2 contin-
gency tables for genotype and allele frequency distribu-
tions, respectively. The P-values for association of IL1RA
VNTR with cerebral malaria were calculated based on 5 ×
2 and 4 × 2 contingency tables for genotype and allele fre-
quency distributions, respectively. Furthermore, Fisher's
exact test was carried out for the comparison of each gen-
otype frequency between mild and cerebral malaria
patients based on 2 × 2 table for IL1B -31C>T and IL1RA
VNTR. The frequencies of haplotype consisting of IL1B -
31C>T and IL1RA  VNTR were estimated based on EM
algorithm [19] using Arlequin software [17]. The differ-
ence in haplotype frequency distribution between mild
and cerebral malaria patiens was assessed by a likelihood
ratio test. In the EM algorithm for the estimation of hap-
lotype frequency, the logarithm of likelihood of theMalaria Journal 2005, 4:38 http://www.malariajournal.com/content/4/1/38
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sample, ln L, was maximized in each subject group (i.e.,
lnLm for mild malaria subjects, lnLc for cerebral malaria
subjects, and lnLall for the combined subjects). The likeli-
hood-ratio statistic was defined by LR = 2 [lnLm + lnLc -
lnLall], which had an approximate χ2 distribution with 7
degrees of freedom under the null hypothesis of no differ-
ence in haplotype frequency distribution. It should be
noted here that there were 8 possible haplotypes, thus the
degree of freedom was 7 in the analysis. The P-values for
association of genotypes of IL1B  -31C>T and TNFA  -
308G>A with cerebral malaria were calculated by Fisher's
exact test based on 2 × 2 contingency table for each
genotype.
Results
Because only the 3953C/C genotype was found in 16
patients with mild malaria and 16 patients with cerebral
malaria in the polymorphism screening, a further geno-
typing was not performed. The genotype and allele fre-
quencies of the IL1B  -31C>T and IL1RA  VNTR
polymorphisms in Thai malaria patients are shown in
Tables 1 and 2. It should be noted that some patients were
not genotyped for both IL1B -31C>T and IL1RA VNTR
because the target fragment was not amplified by PCR. In
Thai malaria patients, the population frequencies of the -
31C and -31T alleles were nearly equal, and allele 4 (with
four repeats) was predominant in the IL1RN VNTR poly-
morphism. Genotype frequencies did not deviate from
predictions of the Hardy-Weinberg equilibrium either in
Table 1: Genotype and allele frequencies of IL1B -31C/T polymorphism in Thai malaria patients.
Mild malaria (n = 192) Cerebral malaria (n = 106) Association P-valuea
Genotype
IL1B -31C>T
C/C 55 (0.286) 28 (0.264) 0.82
C/T 91 (0.474) 49 (0.462)
T/T 46 (0.240) 29 (0.274)
Allele
IL1B -31C>T
C2 0 1  ( 0 . 5 2 3 ) 1 0 5  (0.495) 0.55
T 183 (0.477) 107 (0.505)
Frequencies are in parentheses.
aP-values were calculated by the Fisher's exact test based on 3 × 2 and 2 × 2 contingency tables for genotype and allele frequency, respectively.
Table 2: Genotype and allele frequencies of IL1RA VNTR polymorphism in Thai malaria patients.
Mild malaria (n = 203) Cerebral malaria (n = 109) Association P-valuea
Genotype
2/2b 2 (0.010) 2 (0.018) 0.88
2/4 42 (0.207) 24 (0.220)
3/4 3 (0.015) 1 (0.009)
4/4 154 (0.759) 82 (0.752)
4/5 2 (0.010) 0 (0.000)
Allele
IL1RA
2 46 (0.113) 28 (0.128) 0.84
3 3 (0.007) 1 (0.005)
4 355 (0.874) 189 (0.867)
5 2 (0.005) 0 (0.000)
Frequencies are in parentheses.
a P-values were calculated by the Fisher's exact test based on 5 × 2 and 4 × 2 contingency tables for genotype and allele frequency, respectively.
bIt should be noted here that allele with n repeats of VNTR is designated as "n" in this table.Malaria Journal 2005, 4:38 http://www.malariajournal.com/content/4/1/38
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IL1B -31C>T (for mild malaria patients, P = 0.58; for cer-
ebral malaria patients, P = 0.44) or in IL1RA VNTR (for
mild malaria patients, P = 0.27; for cerebral malaria
patients, P = 0.73). Significant differences in genotype and
allele frequency distributions were not observed between
mild and cerebral malaria patients for IL1B -31C>T or
IL1RA VNTR (Tables 1 and 2). In addition, there was no
difference in each genotype frequency between mild and
cerebral malaria patients (data not shown).
The LD between IL1B -31C>T and IL1RA VNTR was not
strong in the studied population (for mild malaria
patients, P = 0.14 by likelihood ratio test based on a per-
mutation precedure; for cerebral malaria patients, P =
0.50 by likelihood ratio test based on a permutation
precedure). The estimated frequencies of haplotype con-
sisting of IL1B -31C>T and IL1RA VNTR polymorphisms
were shown in Table 3. No significant difference in the
estimated haplotype frequency distribution was detected
by a likelihood ratio test (P = 0.60).
Because several association tests were performed for IL1B
-31C>T, IL1RA VNTR, or the haplotype, the obtained P-
values should be corrected based on the number of test-
ings by using a proper method (e.g., Bonferroni's correc-
tion). However, none of raw P-values for the association
tests were less than 0.05. Thus, the corrected P-values are
not presented in this study.
Discussion
In this study, possible association of IL1B -31C>T and
IL1RA VNTR polymorphisms with cerebral malaria was
assessed in 316 Thai malaria patients. These polymor-
phisms were found not to be associated with cerebral
malaria. If the increased expression of IL-1B observed in
brain of cerebral malaria patients [2,3] is due to the
increased transcription of IL1B caused by the IL1B -31T
allele [11], the frequency of IL1B -31T should be higher in
cerebral malaria patients than in mild malaria patients.
However, the allele frequency of IL1B -31T was not signif-
icantly higher in the cerebral malaria patients. Because the
allele frequency of IL1B -31T is approximately 0.5 in the
studied population, the present study yields a statistical
power high enough for the detection of an association
between IL1B -31T and cerebral malaria unless the associ-
ation is very weak. For example, according to the formurae
for calculation of statistical power developed by Ohashi et
al. [20], when the penetrances for the onset of cerebral
malaria are 0.04 for -31T/-31T, 0.02 for -31C/-31T, and
0.01 for -31C/-31C, the estimated power of this study
with the significance level of 0.05 exceeds 0.98.
The plasma level of IL1-RA was influenced by the number
of repeats in the IL1RA VNTR [13], and the allele with two
repeats (designated as allele 2 in the present study) has
been reported to be associated with various diseases. Like
IL1B -31T, our study yields a high statistical power for
allele 2 of IL1RA VNTR if the association is not weak.
However, neither IL1B -31C>T nor IL1RA VNTR showed
any association with cerebral malaria. Furthermore, geno-
type combinations of these polymorphisms were not
associated with cerebral malaria (data not shown). The
present results are consistent with previous ones in Gam-
bia, where these polymorphisms are not associated with
cerebral malaria [5]. Taken together, we conclude that the
IL1B  -31C>T and IL1RA  VNTR polymorphisms do not
play a crucial role in susceptibility or resistance to cerebral
malaria.
IL-1 is known to synergize with tumor necrosis factor-α
(TNF-α), and their serum levels are thought to play a role
in the severity of malaria [21]. The promoter allele of TNF-
α gene (TNFA),  TNFA  -308A, was reported to be
associated with susceptibility to cerebral malaria in Gam-
bia [22]. Although TNFA -308A was not associated with
cerebral malaria in our previous study for the same Thai
malaria patients [23], it is interesting to examine the
possible association of combined genotypes of IL1B  -
31C>T and TNFA -308G>A polymorphisms with cerebral
malaria. Table 4 shows the frequencies of nine combined
genotypes of IL1B -31C>T and TNFA -308G>A in mild
and cerebral malaria patients. There was no significant dif-
Table 3: Estimated haplotype frequencies of IL1B -31C>T and IL1RA VNTR polymorphisms in Thai malaria patients.
Haplotypea Mild malaria Cerebral malaria Association P-valueb
IL1B – IL1RA
-31C - 2c 0.042 0.046 0.60
-31T - 2 0.072 0.084
-31C - 4 0.432 0.454
-31T - 4 0.443 0.414
aOnly haplotypes with the estimated haplotype frequency of more than 0.01 were presented.
bP-value was calculated by a likelihood ratio test.
cIt should be noted here that allele with n repeats of VNTR is designated as "n" in this table.Malaria Journal 2005, 4:38 http://www.malariajournal.com/content/4/1/38
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ference in each genotype frequency between mild and cer-
ebral malaria patients, suggests that there is no interactive
effect of two polymorphisms on the risk of cerebral
malaria.
IL1B and IL1RA are located closely on human chromo-
some 2. Although IL1RA VNTR is in strong LD with IL1B
polymorphisms, such as IL1B -511C>T, IL1B -31C>T, and
IL1B 3953C>T in Caucasian populations [12,10,21], sig-
nificant LD was not observed between IL1RA VNTR and
IL1B -31C>T in the Thai population. In Indonesians, LD
was not found even between IL1B -31C>T and 3953C>T
[11]. These observations suggest that the structure of LD
in the IL1 gene cluster differs among populations. Because
significant LD was not observed between IL1B and IL1RA
in the present study, we cannot exclude the possibility that
polymorphisms in the other IL1  family genes located
between IL1B and IL1RA, such as IL1 family member 9
(IL1F9) and IL1 family member 8 isoform 1 (IL1F8), are
associated with cerebral malaria. It is currently unknown
whether associations between IL1B 3953C>T and cerebral
malaria [5] or parasitemia [6] in African populations
result from a LD with other functional polymorphisms in
this chromosomal region. Thus, further studies of various
populations are required to clarify whether polymor-
phisms of IL1 family genes are involved in the pathogen-
esis of cerebral malaria.
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